No abstract

By optimizing the main materials in lithium‐air batteries, namely sulfolane as electrolyte solvent, lithium bis(trifluoromethanesulfonyl)imide (LiTFSI) as electrolyte salt, carbon paper as current collector, and Li2O2–C hybrids as positive electrode materials, a performance of 800 cycles with a specific capacity of 1000 mAh g−1 (based on the total mass of positive electrode materials) and an average energy efficiency of 74.72% has been achieved in this work and for the first time reported in the field of lithium‐air battery. Sulfolane‐based electrolyte and carbon paper current collector play the most critical role in building such a lithium‐air battery of high cycle life. The findings described here are expected to benefit the pursuit of green, sustainable, and high‐performance lithium‐air batteries.

Combing Cu and Ag in alloy state holds promise to serve as tandem catalyst for electrocatalytic CO2 reduction but is restricted by immiscibility in the bulk. Here, a far-from-equilibrium method...

By definition, normal healthy volunteers are assumed not to react to a TV/PC screen provocation. To our great surprise, this proved not to be true. The present results might lay a foundation to understand the underlying cause of so-called "screen dermatitis" with special reference to mast cells. However, blind or double-blind experiments using patients ought to be further investigated in order to find out the exact cause for the observed changes. Such causes include the effects of surrounding airborne chemicals, stress factors, etc.

This study reports a facile approach to construct versatile zein-polydopamine-casein core–shell nanocomposites (ZPCs) for polyphenol delivery systems. The surface of zein particles was first modified with mussel-inspired polydopamine (PDA), and then coated with casein, forming stable colloidal particles against environmental stresses including pH, salinity, storage, redispersion, and UV irradiation. Compared with free resveratrol (RES), the encapsulation of RES into ZPCs (RES-ZPCs) enhanced approximately 5-fold and 2.5-fold antioxidant activity for DPPH and ABTS assays, respectively. Cellular H2O2 scavenging assay of RES-ZPCs presents 100% exogenous reactive oxygen species elimination, whereas free RES eliminates only 63.5%. In vitro cell uptake and cytotoxicity assays show that ZPCs could be uptake and exhibits nontoxic on the cell proliferation. This concept of combining PDA and polyphenols with antioxidant activity and stability may provide new insights into designing highly active, stable polyphenol delivery systems and holds promise for applications in food, dietary supplement, and pharmaceutical industries.

No abstract

No abstract

Background: Xpert MTB/RIF (Xpert) is an automated molecular test recommended by World Health Organization (WHO) for diagnosis of tuberculosis (TB). This study evaluated the effect of Xpert implementation on the detection of pulmonary TB (PTB) and rifampicin-resistant TB (RR-TB) cases in Shanghai, China.Methods: Xpert was routinely implemented in 2018 for all presumptive PTB patients. All PTB patients above 15 years-old identified within the Provincial TB Control Program during the first half of each of 2017 and 2018, were enrolled to compare the difference in proportions of bacteriological confirmation, patients with drug susceptibility test (DST) results for rifampicin (ie, DST coverage) and RR-TB detection before and after Xpert's implementation. Results: A total of 6047 PTB patients were included in the analysis with 1691 tested by Xpert in 2018. Percentages of bacteriological confirmation, DST coverage and RR-TB detection in 2017 and 2018 were 50% vs. 59%, 36% vs. 49% and 2% vs. 3%, respectively (all p-values < 0.05). Among 1103 PTB patients who completed sputum smear, culture and Xpert testing in 2018, Xpert detected an additional 121 (11%) PTB patients who were negative by smear and culture, but missed 248 (23%) smear and/or culture positive patients. Besides, it accounted for an increase of 9% in DST coverage and 1% in RR-TB detection. The median time from first visit to a TB hospital to RR-TB detection was 62 days (interquartile range -IQR 48-84.2) in 2017 vs. 9 days (IQR 2-45.7) in 2018 (p-value < 0.001). In the multivariate model, using Xpert was associated with decreased time to RR-TB detection (adjusted hazard ratio = 4.62, 95% confidence interval: 3.18-6.71). Conclusions: Integrating Xpert with smear, culture and culture-based DST in a routine setting significantly increased bacteriological confirmation, DST coverage and RR-TB detection with a dramatic reduction in the time to RR-TB diagnosis in Shanghai, China. Our findings can be useful for other regions that attempt to integrate Xpert into routine PTB and RR-TB case-finding cascade. Further study should focus on the identification and elimination of operational level challenges to fully utilize the benefit of rapid diagnosis by Xpert.